Baillie Gifford US Discovery K (BGUKX)
5.63
0.00 (0.00%)
USD |
Aug 11 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.82% | 3.410M | 0.00% | 6.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 3.762M | -43.07% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund seeks to meet its objective by investing in a portfolio of common stocks and other equity securities of smaller, publicly traded U.S. companies that are perceived to be innovative and entrepreneurial, such as by disrupting existing markets or creating entirely new ones, and that have strong growth potential. It invests at least 80% of its net assets in securities of issuers located in the U.S. The fund invests in equity securities either directly or indirectly, such as through depositary receipts, and may invest in preferred stocks, convertible securities and warrants. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | BGUIX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Growth |
| Category Index | Russell 2000 Growth TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Baillie Gifford Funds |
| Prospectus Benchmark Index | |
| Russell 2500 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Douglas Brodie | 1.24 yrs |
| Svetlana Viteva | 1.24 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
28
3.762M
-2.399B
Category Low
913.51M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of July 31, 2022
Performance Versus Category
As of August 10, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of August 10, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| ShockWave Medical Inc | 5.14% | 281.41 | 1.44% |
| CyberArk Software Ltd | 3.92% | 145.58 | -2.78% |
| Sprout Social Inc Class A | 3.72% | 64.57 | -3.34% |
| Pacira BioSciences Inc | 3.40% | 56.20 | -1.77% |
| Upwork Inc | 3.36% | 18.96 | -5.62% |
| Axon Enterprise Inc | 3.18% | 124.10 | -1.56% |
| Staar Surgical Co | 3.11% | 102.05 | 16.71% |
| AeroVironment Inc | 3.06% | 93.26 | -0.25% |
| BlackLine Inc | 3.01% | 67.94 | -2.76% |
| Trupanion Inc | 2.99% | 75.47 | 4.31% |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund seeks to meet its objective by investing in a portfolio of common stocks and other equity securities of smaller, publicly traded U.S. companies that are perceived to be innovative and entrepreneurial, such as by disrupting existing markets or creating entirely new ones, and that have strong growth potential. It invests at least 80% of its net assets in securities of issuers located in the U.S. The fund invests in equity securities either directly or indirectly, such as through depositary receipts, and may invest in preferred stocks, convertible securities and warrants. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | BGUIX |
| Equity Style | Small Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Growth |
| Category Index | Russell 2000 Growth TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Baillie Gifford Funds |
| Prospectus Benchmark Index | |
| Russell 2500 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Douglas Brodie | 1.24 yrs |
| Svetlana Viteva | 1.24 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (8-10-22) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of June 30, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 5/5/2021 |
| Last Annual Report Date | 12/31/2021 |
| Last Prospectus Date | 7/2/2021 |
| Share Classes | |
| BGUIX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |